Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TLR4 | O00206 | 11/20 | 0.37 |
| ▸ | SELP | P16109 | 3/20 | 0.35 |
| ▸ | LGALS8 | O00214 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | MCHR1 | Q99705 | 2/20 | 0.32 |
| ▸ | SSTR2 | P30874 | 1/20 | 0.32 |
| ▸ | SSTR3 | P32745 | 1/20 | 0.32 |
| ▸ | SSTR5 | P35346 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8579370 | 0.90 | TLR4 (0.37) | TLR4SELPKMT2ALMNA | |
| SCHEMBL8578333 | 0.84 | TLR4 (0.44) | TLR4 | |
| SCHEMBL8580554 | 0.84 | TLR4 (0.44) | TLR4 | |
| SCHEMBL9019224 | 0.84 | TLR4 (0.51) | TLR4SELP | |
| SCHEMBL9019285 | 0.84 | TLR4 (0.51) | TLR4SELP | |
| SCHEMBL9019087 | 0.82 | TLR4 (0.42) | TLR4SELPLGALS8 | |
| SCHEMBL8581934 | 0.82 | TLR4 (0.37) | TLR4SELP | |
| SCHEMBL8578445 | 0.79 | TLR4 (0.38) | TLR4KMT2AMEN1ALDH1A1HPGD | |
| SCHEMBL10960734 | 0.77 | MCHR1 (0.48) | SELPMCHR1SSTR2SSTR3SSTR5 | |
| SCHEMBL9019104 | 0.77 | TLR4 (0.44) | TLR4SELPLGALS8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5792840-A | SUBSTITUTED GLUCOPYRANOSYL PHOSPHATES | SANKYO COMPANY, LIMITED (JP) | 1998-08-11 | — | — | US | disclosed |